PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29883801-0	2019	Glucose-derived acetate and ACSS2 as key players in cisplatin resistance in bladder cancer.	Cisplatin	52-61	acyl-CoA synthetase short chain family member 2	Homo sapiens	28-33	
29883801-7	2019	The relevance of ACSS2 in cisplatin resistance was further confirmed by the abrogation of resistance by an ACSS2 inhibitor and, finally, by the higher expression of ACSS2 in the patient tissues with cisplatin resistance.	Cisplatin	26-35	acyl-CoA synthetase short chain family member 2	Homo sapiens	17-22	
29883801-7	2019	The relevance of ACSS2 in cisplatin resistance was further confirmed by the abrogation of resistance by an ACSS2 inhibitor and, finally, by the higher expression of ACSS2 in the patient tissues with cisplatin resistance.	Cisplatin	26-35	acyl-CoA synthetase short chain family member 2	Homo sapiens	107-112	
29883801-7	2019	The relevance of ACSS2 in cisplatin resistance was further confirmed by the abrogation of resistance by an ACSS2 inhibitor and, finally, by the higher expression of ACSS2 in the patient tissues with cisplatin resistance.	Cisplatin	26-35	acyl-CoA synthetase short chain family member 2	Homo sapiens	107-112	
29883801-7	2019	The relevance of ACSS2 in cisplatin resistance was further confirmed by the abrogation of resistance by an ACSS2 inhibitor and, finally, by the higher expression of ACSS2 in the patient tissues with cisplatin resistance.	Cisplatin	199-208	acyl-CoA synthetase short chain family member 2	Homo sapiens	17-22	
29883801-7	2019	The relevance of ACSS2 in cisplatin resistance was further confirmed by the abrogation of resistance by an ACSS2 inhibitor and, finally, by the higher expression of ACSS2 in the patient tissues with cisplatin resistance.	Cisplatin	199-208	acyl-CoA synthetase short chain family member 2	Homo sapiens	107-112	
29883801-7	2019	The relevance of ACSS2 in cisplatin resistance was further confirmed by the abrogation of resistance by an ACSS2 inhibitor and, finally, by the higher expression of ACSS2 in the patient tissues with cisplatin resistance.	Cisplatin	199-208	acyl-CoA synthetase short chain family member 2	Homo sapiens	107-112	
31638228-6	2019	Moreover, it was shown that ACSS2 inhibition by siRNA not only greatly interfered with proliferation under NS but also participated in DNA repair after cisplatin treatment via PCNA suppression, and the acceleration of cell death was dependent on the activation of the AMPK pathway as revealed by the Annexin V/PI and TUNEL assay results.	Cisplatin	152-161	acyl-CoA synthetase short chain family member 2	Homo sapiens	28-33	
31558821-8	2019	The results indicate that EP + CsP significantly downregulated 14 key glycolysis proteins (including ENO1, LDHA, LDHB, ACSS2, ALDOA, and PGK1), compared to CsP alone.	Cisplatin	31-34	acyl-CoA synthetase short chain family member 2	Homo sapiens	119-124